Pembrolizumab in Muscle-invasive Bladder Cancer

Clinical trial NCT05406713 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05406713
Sponsor: Matthew Galsky
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle Invasive Bladder Carcinoma Localized Cancer Urothelial Carcinoma

Start date: 2022-07-13
Primary completion: 2027-01-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.